RESEARCH-USE BIOSIMILAR ANTIBODY
Solanezumab
Monoclonal antibody · IgG1
Solanezumab (LY-2062430) is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab binds to the mid-domain of monomeric amyloid-beta to slow brain amyloid accumulation. Solanezumab can be used for the research of Alzheimer’s disease.
TARGETAPP
YMonoclonal antibody
CATALOGSC-BS-154
CATALOG NUMBERSC-BS-154
MOLECULAR WEIGHTApprox. 144.8 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Solanezumab (LY-2062430) is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-β (Aβ) peptide. Solanezumab binds to the mid-domain of monomeric amyloid-beta to slow brain amyloid accumulation. Solanezumab can be used for the research of Alzheimer’s disease.
Solanezumab is a recombinant research-use antibody directed against APP.